These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18833969)

  • 21. Pathophysiological mechanisms underlying ventricular dyssynchrony.
    Cheng A; Helm RH; Abraham TP
    Europace; 2009 Nov; 11 Suppl 5():v10-14. PubMed ID: 19861385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceleration-dependent left bundle branch block with severe left ventricular dyssynchrony results in acute heart failure: are there more patients who benefit from cardiac resynchronization therapy?
    Zeppenfeld K; Schalij MJ; Bleeker GB; Holman ER; Bax JJ
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):101-3. PubMed ID: 16426411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular endocardial leadless pacing brings new hope to patients with heart failure.
    Wang HX; Li XF; Zhang H; Sun S
    Int J Cardiol; 2013 Aug; 167(3):1073-4. PubMed ID: 23168008
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac resynchronization therapy for treatment of heart failure.
    Ho JK; Mahajan A
    Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial load reduction after cardiac resynchronization therapy: why does it change?
    Zócalo Y; Bia D; Reyes-Caorsi W; González-Moreno J; Armentano RL
    Eur J Echocardiogr; 2009 Jun; 10(4):461-2; author reply 462-3. PubMed ID: 19398475
    [No Abstract]   [Full Text] [Related]  

  • 27. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pacing in heart failure patients with narrow QRS: is there more to gain than resynchronization?
    Smiseth OA; Russell K; Remme EW
    Circulation; 2009 Oct; 120(17):1651-3. PubMed ID: 19822804
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimization techniques in cardiac resynchronization therapy.
    Fischer A
    Future Cardiol; 2009 Jul; 5(4):355-65. PubMed ID: 19656060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
    Botto GL; Luzi M; Russo G; Mariconti B
    G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
    [No Abstract]   [Full Text] [Related]  

  • 31. Contemporary issues in cardiac pacing.
    Schnorr B; Kelsch B; Cremers B; Clever YP; Speck U; Scheller B
    Minerva Cardioangiol; 2010 Dec; 58(6):677-90. PubMed ID: 21135808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dyssynchrony.
    Abraham WT
    Circulation; 2006 Dec; 114(24):2692-8; discussion 2698. PubMed ID: 17159075
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiac resynchronization therapy: a new frontier in the management of heart failure.
    Gurevitz O; Glikson M
    Isr Med Assoc J; 2003 Aug; 5(8):571-5. PubMed ID: 12929296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.
    van Bommel RJ; Bax JJ; Abraham WT; Chung ES; Pires LA; Tavazzi L; Zimetbaum PJ; Gerritse B; Kristiansen N; Ghio S
    Eur Heart J; 2009 Oct; 30(20):2470-7. PubMed ID: 19717847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010.
    Linde C; Daubert C
    Circulation; 2010 Sep; 122(10):1037-43. PubMed ID: 20823398
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in heart failure.
    Auricchio A; Fantoni C
    Ital Heart J; 2005 Mar; 6(3):256-60. PubMed ID: 15875517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy in patients with minimally symptomatic heart failure.
    Venkataraman G; Strickberger SA
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):959-63. PubMed ID: 20602557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac resynchronization therapy in refractory heart failure].
    Lelakowski J; Czunko A; Majewski J; Bednarek J; Małecka B; Dreher A; Kołacz P
    Pol Merkur Lekarski; 2005 Apr; 18(106):440-5. PubMed ID: 16161931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.